{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:28:36Z","timestamp":1788276516544,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473955, 82574740, 82003165"],"award-info":[{"award-number":["82473955, 82574740, 82003165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"DOI":"10.1186\/s40364-026-00984-2","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T09:24:13Z","timestamp":1786353853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting breast cancer stem cells by restoring RBM38 function: mechanism and protein delivery therapy"],"prefix":"10.1186","volume":"14","author":[{"given":"Jun","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengtao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoman","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2183-4974","authenticated-orcid":false,"given":"Lufeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"issue":"1","key":"984_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"Cancer J Clin"},{"issue":"7","key":"984_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s12032-021-01524-8","volume":"38","author":"JR Lim","year":"2021","unstructured":"Lim JR, Mouawad J, Gorton OK, Bubb WA, Kwan AH. Cancer stem cell characteristics and their potential as therapeutic targets. Med Oncol. 2021;38(7):76.","journal-title":"Med Oncol"},{"issue":"1","key":"984_CR3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41420-023-01427-9","volume":"9","author":"DW Yeh","year":"2023","unstructured":"Yeh DW, Zhao X, Siddique HR, Zheng M, Choi HY, Machida T, et al. MSI2 promotes translation of multiple IRES-containing oncogenes and virus to induce self-renewal of tumor initiating stem-like cells. Cell death discovery. 2023;9(1):141.","journal-title":"Cell death discovery"},{"issue":"1","key":"984_CR4","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1038\/s41467-023-38001-x","volume":"14","author":"F Herrejon Chavez","year":"2023","unstructured":"Herrejon Chavez F, Luo H, Cifani P, Pine A, Chu KL, Joshi S, et al. RNA binding protein SYNCRIP maintains proteostasis and self-renewal of hematopoietic stem and progenitor cells. Nat Commun. 2023;14(1):2290.","journal-title":"Nat Commun"},{"issue":"11","key":"984_CR5","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/s41388-022-02198-w","volume":"41","author":"H Zou","year":"2022","unstructured":"Zou H, Luo J, Guo Y, Liu Y, Wang Y, Deng L, et al. RNA-binding protein complex LIN28\/MSI2 enhances cancer stem cell-like properties by modulating Hippo-YAP1 signaling and independently of Let-7. Oncogene. 2022;41(11):1657\u201372.","journal-title":"Oncogene"},{"issue":"39","key":"984_CR6","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1038\/s41388-022-02439-y","volume":"41","author":"H Ling","year":"2022","unstructured":"Ling H, Cao CH, Han K, Lv YR, Ma XD, Cao JH, et al. CEP63 upregulates YAP1 to promote colorectal cancer progression through stabilizing RNA binding protein FXR1. Oncogene. 2022;41(39):4433\u201345.","journal-title":"Oncogene"},{"issue":"22","key":"984_CR7","doi-asserted-by":"crossref","first-page":"8799","DOI":"10.3390\/ijms21228799","volume":"21","author":"S Muraoka","year":"2020","unstructured":"Muraoka S, Fukumura K, Hayashi M, Kataoka N, Mayeda A, Kaida D. RBM38 Reduces the Transcription Elongation Defect of the SMEK2 Gene Caused by Splicing Deficiency. Int J Mol Sci. 2020;21(22):8799.","journal-title":"Int J Mol Sci"},{"issue":"21","key":"984_CR8","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1101\/gad.1463306","volume":"20","author":"L Shu","year":"2006","unstructured":"Shu L, Yan W, Chen X. RNPC1, an RNA-binding protein and a target of the p53 family, is required for maintaining the stability of the basal and stress-induced p21 transcript. Genes Dev. 2006;20(21):2961\u201372.","journal-title":"Genes Dev"},{"issue":"52","key":"984_CR9","doi-asserted-by":"crossref","first-page":"18637","DOI":"10.1073\/pnas.1415607112","volume":"111","author":"J Zhang","year":"2014","unstructured":"Zhang J, Xu E, Ren C, Yan W, Zhang M, Chen M, et al. Mice deficient in RBM38, a target of the p53 family, are susceptible to accelerated aging and spontaneous tumors. Proc Natl Acad Sci USA. 2014;111(52):18637\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"984_CR10","doi-asserted-by":"crossref","first-page":"165939","DOI":"10.1016\/j.bbadis.2020.165939","volume":"1867","author":"S Smeltzer","year":"2021","unstructured":"Smeltzer S, Quadri Z, Miller A, Zamudio F, Hunter J, Stewart NJF, et al. Hypusination of Eif5a regulates cytoplasmic TDP-43 aggregation and accumulation in a stress-induced cellular model. Biochim et Biophys acta Mol basis disease. 2021;1867(1):165939.","journal-title":"Biochim et Biophys acta Mol basis disease"},{"key":"984_CR11","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1016\/j.csbj.2022.11.018","volume":"20","author":"R Francisco-Velilla","year":"2022","unstructured":"Francisco-Velilla R, Embarc-Buh A, Abellan S, Del Ca\u00f1o-Ochoa F, Ram\u00f3n-Maiques S, Martinez-Salas E. Phosphorylation of T897 in the dimerization domain of Gemin5 modulates protein interactions and translation regulation. Comput Struct Biotechnol J. 2022;20:6182\u201391.","journal-title":"Comput Struct Biotechnol J"},{"issue":"48","key":"984_CR12","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.1038\/onc.2015.31","volume":"34","author":"M Zhang","year":"2015","unstructured":"Zhang M, Xu E, Zhang J, Chen X. PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38. Oncogene. 2015;34(48):5900\u201311.","journal-title":"Oncogene"},{"issue":"20","key":"984_CR13","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1101\/gad.221739.113","volume":"27","author":"M Zhang","year":"2013","unstructured":"Zhang M, Zhang J, Chen X, Cho SJ, Chen X. Glycogen synthase kinase 3 promotes p53 mRNA translation via phosphorylation of RNPC1. Genes Dev. 2013;27(20):2246\u201358.","journal-title":"Genes Dev"},{"issue":"7\u20138","key":"984_CR14","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1101\/gad.346148.120","volume":"35","author":"W Sun","year":"2021","unstructured":"Sun W, Laubach K, Lucchessi C, Zhang Y, Chen M, Zhang J, et al. Fine-tuning p53 activity by modulating the interaction between eukaryotic translation initiation factor eIF4E and RNA-binding protein RBM38. Genes Dev. 2021;35(7\u20138):542\u201355.","journal-title":"Genes Dev"},{"key":"984_CR15","doi-asserted-by":"crossref","unstructured":"Yang Y, Zhu H, Liu D, Luo H, Chang R, Ji Y, et al. A versatile platform for the tumor-targeted intracellular delivery of peptides, proteins, and siRNA. Adv Funct Mater. 2023;33(30):2301011.","DOI":"10.1002\/adfm.202301011"},{"issue":"7","key":"984_CR16","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.apsb.2021.01.008","volume":"11","author":"C Gao","year":"2021","unstructured":"Gao C, Xu Y, Liang Z, Wang Y, Shang Q, Zhang S, et al. A novel PGAM5 inhibitor LFHP-1c protects blood-brain barrier integrity in ischemic stroke. Acta Pharm Sinica B. 2021;11(7):1867\u201384.","journal-title":"Acta Pharm Sinica B"},{"key":"984_CR17","doi-asserted-by":"crossref","unstructured":"Sato M, Inada E, Saitoh I, Watanabe S, Nakamura S. piggyBac-based non-viral in vivo gene delivery useful for production of genetically modified animals and organs. Pharmaceutics. 2020;12(3).","DOI":"10.3390\/pharmaceutics12030277"},{"issue":"17","key":"984_CR18","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1111\/bph.16092","volume":"180","author":"Y Liu","year":"2023","unstructured":"Liu Y, Chen Y, Zhao Q, Xie T, Xiang C, Guo Q, et al. A positive TGF-\u03b2\/miR-9 regulatory loop promotes the expansion and activity of tumour-initiating cells in breast cancer. Br J Pharmacol. 2023;180(17):2280\u201397.","journal-title":"Br J Pharmacol"},{"issue":"Print","key":"984_CR19","first-page":"2162","volume":"21","author":"Q Guo","year":"2020","unstructured":"Guo Q, Wang T, Yang Y, Gao L, Zhao Q, Zhang W, et al. Transcriptional Factor Yin Yang 1 Promotes the Stemness of Breast Cancer Cells by Suppressing miR-873-5p Transcriptional Activity. Mol therapy Nucleic acids. 2020;21(Print):2162\u2013531.","journal-title":"Mol therapy Nucleic acids"},{"issue":"1","key":"984_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13045-019-0697-6","volume":"12","author":"L Zheng","year":"2019","unstructured":"Zheng L, Guo Q, Xiang C, Liu S, Jiang Y, Gao L, et al. Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells. J Hematol Oncol. 2019;12(1):23.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"984_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13045-018-0613-5","volume":"11","author":"L Zheng","year":"2018","unstructured":"Zheng L, Xiang C, Li X, Guo Q, Gao L, Ni H, et al. STARD13-correlated ceRNA network-directed inhibition on YAP\/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase\/F-actin signaling. J Hematol Oncol. 2018;11(1):72.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"984_CR22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/bjc.2017.204","volume":"117","author":"J Wu","year":"2017","unstructured":"Wu J, Zhou XJ, Sun X, Xia TS, Li XX, Shi L, et al. RBM38 is involved in TGF-\u03b2-induced epithelial-to-mesenchymal transition by stabilising zonula occludens-1 mRNA in breast cancer. Br J Cancer. 2017;117(5):675\u201384.","journal-title":"Br J Cancer"},{"issue":"3","key":"984_CR23","first-page":"954","volume":"12","author":"CT Guy","year":"1992","unstructured":"Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol. 1992;12(3):954\u201361.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"984_CR24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ccr.2008.01.011","volume":"13","author":"H Kouros-Mehr","year":"2008","unstructured":"Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, et al. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell. 2008;13(2):141\u201352.","journal-title":"Cancer Cell"},{"issue":"1","key":"984_CR25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ccr.2014.04.027","volume":"26","author":"L Wan","year":"2014","unstructured":"Wan L, Lu X, Yuan S, Wei Y, Guo F, Shen M, et al. MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors. Cancer Cell. 2014;26(1):92\u2013105.","journal-title":"Cancer Cell"},{"issue":"7379","key":"984_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nature10694","volume":"481","author":"I Malanchi","year":"2011","unstructured":"Malanchi I, Santamaria-Martinez A, Susanto E, Peng H, Lehr HA, Delaloye JF, et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature. 2011;481(7379):85\u20139.","journal-title":"Nature"},{"issue":"11","key":"984_CR27","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/ncb3425","volume":"18","author":"T Ni","year":"2016","unstructured":"Ni T, Li XY, Lu N, An T, Liu ZP, Fu R, et al. Snail1-dependent p53 repression regulates expansion and activity of tumour-initiating cells in breast cancer. Nat Cell Biol. 2016;18(11):1221\u201332.","journal-title":"Nat Cell Biol"},{"key":"984_CR28","first-page":"121","volume":"1406","author":"X Jiao","year":"2016","unstructured":"Jiao X, Rizvanov AA, Cristofanilli M, Miftakhova RR, Pestell RG. Breast Cancer Stem Cell Isolation Methods Mol biology. 2016;1406:121\u201335.","journal-title":"Breast Cancer Stem Cell Isolation Methods Mol biology"},{"issue":"17","key":"984_CR29","doi-asserted-by":"crossref","first-page":"23197","DOI":"10.18632\/oncotarget.8099","volume":"7","author":"X Li","year":"2016","unstructured":"Li X, Zheng L, Zhang F, Hu J, Chou J, Liu Y, et al. STARD13-correlated ceRNA network inhibits EMT and metastasis of breast cancer. Oncotarget. 2016;7(17):23197\u2013211.","journal-title":"Oncotarget"},{"issue":"12","key":"984_CR30","doi-asserted-by":"crossref","first-page":"e81423","DOI":"10.1371\/journal.pone.0081423","volume":"8","author":"M Xue","year":"2013","unstructured":"Xue M, Fang Y, Sun G, Zhuo W, Zhong J, Qian C, et al. IGFBP3, a transcriptional target of homeobox D10, is correlated with the prognosis of gastric cancer. PLoS ONE. 2013;8(12):e81423.","journal-title":"PLoS ONE"},{"issue":"20","key":"984_CR31","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1158\/0008-5472.CAN-08-2103","volume":"68","author":"SD Reddy","year":"2008","unstructured":"Reddy SD, Ohshiro K, Rayala SK, Kumar R. MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions. Cancer Res. 2008;68(20):8195\u2013200.","journal-title":"Cancer Res"},{"key":"984_CR32","first-page":"9","volume":"6","author":"H Jin","year":"2012","unstructured":"Jin H, Yu Y, Chrisler WB, Xiong Y, Hu D, Lei C. Delivery of MicroRNA-10b with Polylysine Nanoparticles for Inhibition of Breast Cancer Cell Wound Healing. Breast cancer: basic Clin Res. 2012;6:9\u201319.","journal-title":"Breast cancer: basic Clin Res"},{"issue":"50","key":"984_CR33","doi-asserted-by":"crossref","first-page":"43475","DOI":"10.1074\/jbc.M111.284158","volume":"286","author":"I Haque","year":"2011","unstructured":"Haque I, Banerjee S, Mehta S, De A, Majumder M, Mayo MS, et al. Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)\/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1\u03b1-TWIST signaling networks in human breast cancer cells. J Biol Chem. 2011;286(50):43475\u201385.","journal-title":"J Biol Chem"},{"issue":"16","key":"984_CR34","doi-asserted-by":"crossref","first-page":"7177","DOI":"10.1158\/0008-5472.CAN-04-1717","volume":"65","author":"M Carrio","year":"2005","unstructured":"Carrio M, Arderiu G, Myers C, Boudreau NJ. Homeobox D10 induces phenotypic reversion of breast tumor cells in a three-dimensional culture model. Cancer Res. 2005;65(16):7177\u201385.","journal-title":"Cancer Res"},{"issue":"6","key":"984_CR35","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1021\/acs.molpharmaceut.7b01123","volume":"15","author":"L Zheng","year":"2018","unstructured":"Zheng L, Zhang Z, Zhang S, Guo Q, Zhang F, Gao L, et al. RNA Binding Protein RNPC1 Inhibits Breast Cancer Cell Metastasis via Activating STARD13-Correlated ceRNA Network. Mol Pharm. 2018;15(6):2123\u201332.","journal-title":"Mol Pharm"},{"issue":"5","key":"984_CR36","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/cdd.2014.176","volume":"22","author":"Y Kuwano","year":"2015","unstructured":"Kuwano Y, Nishida K, Kajita K, Satake Y, Akaike Y, Fujita K, et al. Transformer 2beta and miR-204 regulate apoptosis through competitive binding to 3\u2019 UTR of BCL2 mRNA. Cell Death Differ. 2015;22(5):815\u201325.","journal-title":"Cell Death Differ"},{"issue":"1","key":"984_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-020-00927-w","volume":"13","author":"H Qin","year":"2020","unstructured":"Qin H, Ni H, Liu Y, Yuan Y, Xi T, Li X, et al. RNA-binding proteins in tumor progression. J Hematol Oncol. 2020;13(1):90.","journal-title":"J Hematol Oncol"},{"issue":"21","key":"984_CR38","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.1158\/0008-5472.CAN-16-1571","volume":"76","author":"J Kim","year":"2016","unstructured":"Kim J, Siverly AN, Chen D, Wang M, Yuan Y, Wang Y, et al. Ablation of miR-10b Suppresses Oncogene-Induced Mammary Tumorigenesis and Metastasis and Reactivates Tumor-Suppressive Pathways. Cancer Res. 2016;76(21):6424\u201335.","journal-title":"Cancer Res"},{"issue":"4","key":"984_CR39","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1618","volume":"28","author":"L Ma","year":"2010","unstructured":"Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol. 2010;28(4):341\u20137.","journal-title":"Nat Biotechnol"},{"key":"984_CR40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12957-015-0673-8","volume":"13","author":"YY Wang","year":"2015","unstructured":"Wang YY, Li L, Ye ZY, Zhao ZS, Yan ZL. MicroRNA-10b promotes migration and invasion through Hoxd10 in human gastric cancer. World J Surg Oncol. 2015;13:259.","journal-title":"World J Surg Oncol"},{"key":"984_CR41","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12967-014-0234-x","volume":"12","author":"CG Liao","year":"2014","unstructured":"Liao CG, Kong LM, Zhou P, Yang XL, Huang JG, Zhang HL, et al. miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through RhoC, uPAR and MMPs. J Transl Med. 2014;12:234.","journal-title":"J Transl Med"},{"issue":"12","key":"984_CR42","doi-asserted-by":"crossref","first-page":"e83080","DOI":"10.1371\/journal.pone.0083080","volume":"8","author":"X Yu","year":"2013","unstructured":"Yu X, Li Z, Shen J, Wu WK, Liang J, Weng X, et al. MicroRNA-10b promotes nucleus pulposus cell proliferation through RhoC-Akt pathway by targeting HOXD10 in intervetebral disc degeneration. PLoS ONE. 2013;8(12):e83080.","journal-title":"PLoS ONE"},{"issue":"5","key":"984_CR43","first-page":"1553","volume":"40","author":"Z Liu","year":"2012","unstructured":"Liu Z, Zhu J, Cao H, Ren H, Fang X. miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer. Int J Oncol. 2012;40(5):1553\u201360.","journal-title":"Int J Oncol"},{"key":"984_CR44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2011.03.013","volume":"1389","author":"L Sun","year":"2011","unstructured":"Sun L, Yan W, Wang Y, Sun G, Luo H, Zhang J, et al. MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. Brain Res. 2011;1389:9\u201318.","journal-title":"Brain Res"},{"key":"984_CR45","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","volume":"19","author":"B Gy\u0151rffy","year":"2021","unstructured":"Gy\u0151rffy B. Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. Comput Struct Biotechnol J. 2021;19:4101\u20139.","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"984_CR46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13046-017-0521-5","volume":"36","author":"XX Li","year":"2017","unstructured":"Li XX, Shi L, Zhou XJ, Wu J, Xia TS, Zhou WB, et al. The role of c-Myc-RBM38 loop in the growth suppression in breast cancer. J experimental Clin cancer research: CR. 2017;36(1):49.","journal-title":"J experimental Clin cancer research: CR"},{"issue":"4","key":"984_CR47","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.3892\/or.2014.3048","volume":"31","author":"H Xiao","year":"2014","unstructured":"Xiao H, Li H, Yu G, Xiao W, Hu J, Tang K, et al. MicroRNA-10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer. Oncol Rep. 2014;31(4):1832\u20138.","journal-title":"Oncol Rep"},{"issue":"5","key":"984_CR48","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/1061186X.2020.1864739","volume":"29","author":"Z Ruan","year":"2021","unstructured":"Ruan Z, Li Y, He R, Li X. Inhibition of microRNA-10b-5p up-regulates HOXD10 to attenuate Alzheimer\u2019s disease in rats via the Rho\/ROCK signalling pathway. J Drug Target. 2021;29(5):531\u201340.","journal-title":"J Drug Target"},{"key":"984_CR49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-018-0033-6","volume":"3","author":"K Yachi","year":"2018","unstructured":"Yachi K, Tsuda M, Kohsaka S, Wang L, Oda Y, Tanikawa S, et al. miR-23a promotes invasion of glioblastoma via HOXD10-regulated glial-mesenchymal transition. Signal Transduct Target therapy. 2018;3:33.","journal-title":"Signal Transduct Target therapy"},{"issue":"7","key":"984_CR50","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1158\/0008-5472.CAN-20-3157","volume":"81","author":"CA Lucchesi","year":"2021","unstructured":"Lucchesi CA, Zhang J, Ma B, Nussinov R, Chen X. Survivin Expression Is Differentially Regulated by a Selective Cross-talk between RBM38 and miRNAs let-7b or miR-203a. Cancer Res. 2021;81(7):1827\u201339.","journal-title":"Cancer Res"},{"key":"984_CR51","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41523-018-0054-x","volume":"4","author":"A Parkes","year":"2018","unstructured":"Parkes A, Clifton K, Al-Awadhi A, Oke O, Warneke CL, Litton JK, et al. Characterization of bone only metastasis patients with respect to tumor subtypes. NPJ Breast Cancer. 2018;4:2.","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"984_CR52","doi-asserted-by":"crossref","first-page":"112741","DOI":"10.1016\/j.yexcr.2021.112741","volume":"406","author":"CM Ji","year":"2021","unstructured":"Ji CM, Zhang X, Fang W, Meng L, Wei X, Lu C. RNA-binding protein RNPC1 acts as an oncogene in gastric cancer by stabilizing aurora kinase B mRNA. Exp Cell Res. 2021;406(1):112741.","journal-title":"Exp Cell Res"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-026-00984-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00984-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00984-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:11:25Z","timestamp":1788275485000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40364-026-00984-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["984"],"URL":"https:\/\/doi.org\/10.1186\/s40364-026-00984-2","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A retrospective longitudinal cohort comprising two hundred twenty-eight treatment-na\u00efve mammary carcinoma specimens was prospectively archived from patients undergoing primary tumor resection at Xuzhou Medical University Affiliated Hospital during the period spanning January 2011 through May 2016, with longitudinal monitoring persisting through June 2018. Ethical oversight was ensured through formal approval by the Institutional Review Board (XYFY2021-KL038-01). All methods\/study procedures were carried out in accordance with Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"112"}}